Detection and Evaluation of Macrolide Resistance (Erythromycin) in Mycoplasma hominis Isolated from Endocervical Specimens of Patients Referring to Ibn Sina Infertility Treatment Centre, Tehran, Iran
Authors:
Open Access
- 1 April 2022
- journal article
- research article
- Vol. 16 (2) , 95-101
Abstract
Background: Mycoplasma hominis (M. hominis) is an important cause of bacterial infections of the genital tract. Mac-rolides are the first selective agents used to treat mycoplasma infections. However, widespread use of macrolides has led to a rapid and global emergence of macrolide-resistant strains. We evaluated macrolide resistance in M. hominis isolated from endocervical specimens of patients who referred to Ibn Sina Infertility Centre in Tehran, Iran. Materials and Methods: In this cross-sectional descriptive-analytical study, 160 samples of Dacron endocervix swabs (80 infertile patient samples and 80 healthy controls) were collected and transferred to the laboratory. All samples were cultured in liquid pleuropneumonia-like organisms (PPLO) broth and PPLO agar solid media. After culturing and genome extraction, polymerase chain reaction (PCR) was performed using specific primers. Then, mini-mum inhibitory concentration (MIC) was obtained using the broth microdilution method. The MIC was recorded and reported for all samples positive for M. hominis against erythromycin. Results: From the 160 endocervical specimens cultured in PPLO agar medium, 19 cases (23.75%) were positive. A total of 35 cases (42.5%) were positive using specific primers of M. hominis species. MIC results from all samples positive for M. hominis were measured against erythromycin. All of the M. hominis samples were resistant to erythromycin. Conclusion: The results of the present study showed that a significant percentage of infertile women were infected with M. hominis. Also, MIC results from the broth microdilution method indicated that all strains positive for M. homi-nis were also resistant to erythromycin.Keywords
This publication has 19 references indexed in Scilit:
- Prevalence and antimicrobial resistance of Ureaplasma spp. and Mycoplasma hominis isolated from semen samples of infertile men in Shanghai, China from 2011 to 2016European Journal of Clinical Microbiology & Infectious Diseases, 2018
- Prevalence and antimicrobial susceptibility ofUreaplasmaspecies andMycoplasma hominisin Greek female outpatients, 2012–2016Journal of Chemotherapy, 2017
- Antibacterial Resistance in Ureaplasma Species and Mycoplasma hominis Isolates from Urine Cultures in College-Aged FemalesAntimicrobial Agents and Chemotherapy, 2017
- Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009–2013Journal of Microbiology, Immunology and Infection, 2016
- Epidemiology of Ureaplasma urealyticum and Mycoplasma hominis in the semen of male outpatients with reproductive disordersExperimental and Therapeutic Medicine, 2016
- Prevalence of Ureaplasma urealyticum and Mycoplasma hominis in High Vaginal Swab Samples of Infertile FemalesIranian Red Crescent Medical Journal, 2015
- Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant womenInternational Journal of Infectious Diseases, 2010
- PCR versus culture in the detection of vaginalUreaplasma urealyticumandMycoplasma hominisInternational Journal of Gynecology & Obstetrics, 2007
- Mutations in 23S rRNA Account for Intrinsic Resistance to Macrolides in Mycoplasma hominis and Mycoplasma fermentans and for Acquired Resistance to Macrolides in M. hominisAntimicrobial Agents and Chemotherapy, 2002
- Two New Point Mutations at A2062 Associated with Resistance to 16-Membered Macrolide Antibiotics in Mutant Strains of Mycoplasma hominisAntimicrobial Agents and Chemotherapy, 2001